These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28423503)

  • 1. Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system.
    Zhang J; Zhao T; Han F; Hu Y; Li Y
    J Nanobiotechnology; 2019 Jul; 17(1):80. PubMed ID: 31277667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.
    Jin SE; Sung JH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 upregulates PLCĪµ-IP3-Ca
    Di J; Tang J; Qian H; Franklin DA; Deisenroth C; Itahana Y; Zheng J; Zhang Y
    Oncotarget; 2017 Sep; 8(39):64657-64669. PubMed ID: 29029384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-Assisted Chitosan-Functionalized Graphene Oxide as Controlled Intracellular Drug Delivery Nanosystem for Synergistic Antitumour Activity.
    Shu M; Gao F; Zeng M; Yu C; Wang X; Huang R; Yang J; Su Y; Hu N; Zhou Z; Liu K; Yang Z; Tan H; Xu L
    Nanoscale Res Lett; 2021 Apr; 16(1):75. PubMed ID: 33929622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success.
    Kumbhar PR; Kumar P; Lasure A; Velayutham R; Mandal D
    Discov Nano; 2023 Dec; 18(1):156. PubMed ID: 38112935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells.
    Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X
    J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods.
    Wang J; Thomas M; Lin P; Cheng JX; Matei DE; Wei A
    Bioconjug Chem; 2019 Feb; 30(2):443-453. PubMed ID: 30395447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
    Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-activatable gold nanoshells for drug delivery applications.
    Singhana B; Slattery P; Chen A; Wallace M; Melancon MP
    AAPS PharmSciTech; 2014 Jun; 15(3):741-52. PubMed ID: 24550102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of siRNA delivery strategy by active control of tumor microenvironment].
    Ishida T; Kiwada H
    Yakugaku Zasshi; 2013; 133(3):379-86. PubMed ID: 23449418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system.
    Ding L; Sun R; Zhang X
    Oncotarget; 2017 Mar; 8(13):21200-21211. PubMed ID: 28423503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
    Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
    Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.